Golden Biotechnology Corporation engages in research and development of new drug in Taiwan. The company offers Antroquinonol for the treatment of pancreatic cancer, acute myeloid leukemia, blood diseases, non-small cell lung cancer, COVID-19, and other diseases. It is also involved in development and sale of health foods and supplements, as well as provides products for oncology, infectious, and neurodegenerative diseases. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Frequently asked questions
What sector does Golden Biotechnology Corporation (4132) operate in?
Golden Biotechnology Corporation belongs to the Other sector and operates in the industry.
What is Golden Biotechnology Corporation (4132) current stock price?
As of the latest data, Golden Biotechnology Corporation stock price is NT$3.47, with a previous close of NT$3.47.
What is Golden Biotechnology Corporation (4132) current market capitalization?
Golden Biotechnology Corporation market cap is approximately 632.33 million.
What is Golden Biotechnology Corporation (4132) Earnings Per Share (EPS)?
The trailing EPS is -NT$1.92.
Does Golden Biotechnology Corporation (4132) pay dividends?
No. Golden Biotechnology Corporation does not pay a dividend.
What is Golden Biotechnology Corporation (4132) beta (volatility) score?
Golden Biotechnology Corporation has a beta of 1.084, meaning its volatility is roughly in line with the market.